广康生化
(300804)
| 流通市值：12.50亿 | | | 总市值：33.63亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 382,211,123.05 | 160,416,302.71 | 754,799,505.24 | 549,873,806.69 |
| 营业收入 | 382,211,123.05 | 160,416,302.71 | 754,799,505.24 | 549,873,806.69 |
| 二、营业总成本 | 378,926,709.86 | 162,627,495.93 | 713,052,217.39 | 515,527,922.51 |
| 营业成本 | 301,840,571.96 | 129,645,247.42 | 572,564,464.1 | 415,091,113.22 |
| 税金及附加 | 1,171,762.1 | 583,703.18 | 2,153,297.78 | 1,574,119.47 |
| 销售费用 | 9,367,934.63 | 3,706,152.95 | 17,468,195.95 | 12,568,803.46 |
| 管理费用 | 37,856,284.52 | 15,382,921.43 | 68,012,945.88 | 48,946,471.15 |
| 研发费用 | 17,607,732.1 | 8,334,771.38 | 34,505,761.1 | 25,133,159.54 |
| 财务费用 | 11,082,424.55 | 4,974,699.57 | 18,347,552.58 | 12,214,255.67 |
| 其中:利息费用 | 4,962,631.81 | 2,226,120.19 | 10,589,262.44 | 7,806,130.66 |
| 其中:利息收入 | 668,492.69 | 295,342.76 | 786,262.18 | 454,908.53 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 81,351 | - | 289,556.61 | - |
| 加:投资收益 | 1,656,990.04 | 1,335,783.91 | 6,368,040.75 | 4,817,098.98 |
| 资产处置收益 | 0 | - | -15,128.49 | -15,128.49 |
| 资产减值损失(新) | - | - | -3,024,871.73 | - |
| 信用减值损失(新) | -2,764,755.85 | -437,237.93 | 740,924.76 | 1,619,864.54 |
| 其他收益 | 557,795.27 | 264,796.21 | 1,118,020.39 | 887,163.68 |
| 四、营业利润 | 2,815,793.65 | -1,047,851.03 | 47,223,830.14 | 41,654,882.89 |
| 加:营业外收入 | 36,637.65 | 32,437.65 | 1,299,217.7 | 1,294,355.44 |
| 减:营业外支出 | 1,742,056.68 | 695,501.26 | 5,936,988.05 | 4,109,309.5 |
| 五、利润总额 | 1,110,374.62 | -1,710,914.64 | 42,586,059.79 | 38,839,928.83 |
| 减:所得税费用 | -3,099,599.88 | -1,328,155.27 | 2,168,158.56 | 4,018,867.54 |
| 六、净利润 | 4,209,974.5 | -382,759.37 | 40,417,901.23 | 34,821,061.29 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 4,209,974.5 | -382,759.37 | 40,417,901.23 | 34,821,061.29 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,306,742.02 | -575,458.99 | 40,713,344.1 | 34,848,362.42 |
| 少数股东损益 | 903,232.48 | 192,699.62 | -295,442.87 | -27,301.13 |
| 扣除非经常损益后的净利润 | 2,804,241.55 | -1,374,818.84 | 38,064,759.45 | 32,410,526.75 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.04 | -0.01 | 0.55 | 0.47 |
| (二)稀释每股收益 | 0.04 | -0.01 | 0.55 | 0.47 |
| 八、其他综合收益 | -1,017.57 | - | - | - |
| 归属于母公司股东的其他综合收益 | -1,017.57 | - | - | - |
| 九、综合收益总额 | 4,208,956.93 | -382,759.37 | 40,417,901.23 | 34,821,061.29 |
| 归属于母公司股东的综合收益总额 | 3,305,724.45 | -575,458.99 | 40,713,344.1 | 34,848,362.42 |
| 归属于少数股东的综合收益总额 | 903,232.48 | 192,699.62 | -295,442.87 | -27,301.13 |
| 公告日期 | 2026-08-28 | 2026-04-24 | 2026-04-24 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |